trimetazidine has been researched along with Cardiomegaly in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hang, WJ; Peng, YZ; Shen, L; Shu, HY; Wang, DW; Zhang, M; Zhou, N | 1 |
| Ahangarpour, A; Badavi, M; Dianat, M; Mard, SA; Ramezani-Aliakbari, F | 1 |
| Mansur, AJ | 1 |
| Gai, Y; Gao, W; Li, Z; Liu, F; Liu, X; Xu, M; Zhang, Y | 1 |
| Allard, MF; Bescond-Jacquet, A; Grist, M; Lucien, A; Saeedi, R; Wambolt, RB | 1 |
| Guarnieri, C; Muscari, C | 1 |
6 other study(ies) available for trimetazidine and Cardiomegaly
| Article | Year |
|---|---|
Trimetazidine enhances myocardial angiogenesis in pressure overload-induced cardiac hypertrophy mice through directly activating Akt and promoting the binding of HSF1 to VEGF-A promoter.
Topics: Angiogenesis Inducing Agents; Animals; Cardiomegaly; Heat Shock Transcription Factors; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Myocardium; Myocytes, Cardiac; Neovascularization, Pathologic; Norepinephrine; Promoter Regions, Genetic; Proto-Oncogene Proteins c-akt; Transcription Factors; Trimetazidine; Vascular Endothelial Growth Factor A | 2022 |
The Effects of Trimetazidine on QT-interval Prolongation and Cardiac Hypertrophy in Diabetic Rats.
Topics: Animals; Cardiomegaly; Catalase; Diabetes Complications; Diabetes Mellitus, Experimental; Echocardiography; Glutathione Peroxidase; Hemodynamics; Long QT Syndrome; Male; Protective Agents; Random Allocation; Rats, Sprague-Dawley; Reproducibility of Results; Superoxide Dismutase; Time Factors; Trimetazidine | 2019 |
Cardiac Effects of Trimetazidine in Diabetic Rats.
Topics: Animals; Cardiomegaly; Diabetes Mellitus, Experimental; Heart; Long QT Syndrome; Rats; Trimetazidine | 2019 |
Trimetazidine inhibits pressure overload-induced cardiac fibrosis through NADPH oxidase-ROS-CTGF pathway.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cell Proliferation; Cells, Cultured; Collagen; Connective Tissue Growth Factor; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Fibroblasts; Fibrosis; Hypertension; Male; Malondialdehyde; Myocardium; NADPH Oxidases; rac1 GTP-Binding Protein; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Time Factors; Trimetazidine; Vasodilator Agents | 2010 |
Trimetazidine normalizes postischemic function of hypertrophied rat hearts.
Topics: Adenosine Triphosphate; Animals; Cardiomegaly; Coronary Circulation; Glucose; Glycolysis; Kinetics; Lactic Acid; Male; Myocardial Contraction; Myocardial Ischemia; Myocardium; Oxidation-Reduction; Palmitates; Perfusion; Protons; Rats; Rats, Sprague-Dawley; Trimetazidine; Vasodilator Agents | 2005 |
Beneficial effects of trimetazidine on mitochondrial function and superoxide production in the cardiac muscle of monocrotaline-treated rats.
Topics: Animals; Cardiomegaly; Electron Transport; Lipid Peroxides; Male; Mitochondria, Heart; Monocrotaline; Oxidative Phosphorylation; Oxygen Consumption; Piperazines; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Superoxides; Trimetazidine | 1988 |